Cargando…

Structure Based Design and Molecular Docking Studies for Phosphorylated Tau Inhibitors in Alzheimer’s Disease

The purpose of our study is to identify phosphorylated tau (p-tau) inhibitors. P-tau has recently received great interest as a potential drug target in Alzheimer’s disease (AD). The continuous failure of Aβ-targeted therapeutics recommends an alternative drug target to treat AD. There is increasing...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pradeepkiran, Jangampalli Adi, Reddy, P. Hemachandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6468864/ https://www.ncbi.nlm.nih.gov/pubmed/30893872 http://dx.doi.org/10.3390/cells8030260

Ejemplares similares

Are mitophagy enhancers therapeutic targets for Alzheimer’s disease?
por: Pradeepkiran, Jangampalli Adi, et al.
Publicado: (2022)

Discovery of small molecules through pharmacophore modeling, docking and molecular dynamics simulation against Plasmodium vivax Vivapain-3 (VP-3)
por: Saddala, Madhu Sudhana, et al.
Publicado: (2018)

A partial reduction of VDAC1 enhances mitophagy, autophagy, synaptic activities in a transgenic Tau mouse model
por: Vijayan, Murali, et al.
Publicado: (2022)

Early Cellular, Molecular, Morphological and Behavioral Changes in the Humanized Amyloid-Beta-Knock-In Mouse Model of Late-Onset Alzheimer’s Disease
por: Kshirsagar, Sudhir, et al.
Publicado: (2022)

Rlip76: An Unexplored Player in Neurodegeneration and Alzheimer’s Disease?
por: Hindle, Ashly, et al.
Publicado: (2022)

Rlip Reduction Induces Oxidative Stress and Mitochondrial Dysfunction in Mutant Tau-Expressed Immortalized Hippocampal Neurons: Mechanistic Insights
por: Reddy, P. Hemachandra, et al.
Publicado: (2023)

Modeling, molecular docking, probing catalytic binding mode of acetyl-CoA malate synthase G in Brucella melitensis 16M
por: Adi, Pradeepkiran Jangampalli, et al.
Publicado: (2016)

MicroRNA-455-3p improves synaptic, cognitive functions and extends lifespan: Relevance to Alzheimer's disease
por: Kumar, Subodh, et al.
Publicado: (2021)

Phosphorylated Tau in Alzheimer’s Disease and Other Tauopathies
por: Rawat, Priyanka, et al.
Publicado: (2022)

Modeling, molecular dynamics, and docking assessment of transcription factor rho: a potential drug target in Brucella melitensis 16M
por: Pradeepkiran, Jangampalli Adi, et al.
Publicado: (2015)

Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer’s Disease
por: Reddy, P. Hemachandra, et al.
Publicado: (2019)

A Combination Therapy of Urolithin A+EGCG Has Stronger Protective Effects than Single Drug Urolithin A in a Humanized Amyloid Beta Knockin Mice for Late-Onset Alzheimer’s Disease
por: Kshirsagar, Sudhir, et al.
Publicado: (2022)

Insights of rheumatoid arthritis risk factors and associations
por: Pradeepkiran, Jangampalli Adi
Publicado: (2019)

Aquaculture role in global food security with nutritional value: a review
por: Pradeepkiran, Jangampalli Adi
Publicado: (2019)

Expression and Function of StAR in Cancerous and Non-Cancerous Human and Mouse Breast Tissues: New Insights into Diagnosis and Treatment of Hormone-Sensitive Breast Cancer
por: Manna, Pulak R., et al.
Publicado: (2023)

Conformational transition pathway of R308K mutant glucokinase in the presence of the glucokinase activator YNKGKA4
por: Yellapu, Nanda Kumar, et al.
Publicado: (2018)

Pharmacological Potentiality of Bioactive Flavonoid against Ketamine Induced Cell Death of PC 12 Cell Lines: An In Vitro Study
por: Venkataramaiah, Chintha, et al.
Publicado: (2021)

Complete genome-wide screening and subtractive genomic approach revealed new virulence factors, potential drug targets against bio-war pathogen Brucella melitensis 16M
por: Pradeepkiran, Jangampalli Adi, et al.
Publicado: (2015)

Calcium, zinc and vitamin E ameliorate cadmium-induced renal oxidative damage in albino Wistar rats
por: Adi, Pradeepkiran Jangampalli, et al.
Publicado: (2016)

Reduced VDAC1, Maintained Mitochondrial Dynamics and Enhanced Mitochondrial Biogenesis in a Transgenic Tau Mouse Model of Alzheimer’s Disease
por: Vijayan, Murali, et al.
Publicado: (2022)

Epigenetic Modulation on Tau Phosphorylation in Alzheimer's Disease
por: Yu, Chao-Chao, et al.
Publicado: (2019)

Three Novel Mutations I65S, R66S, and G86R Divulge Significant Conformational Variations in the PTB Domain of the IRS1 Gene
por: Veeraragavulu, Praveen Chakravarthi, et al.
Publicado: (2019)

Novel 1, 4-dihydropyridines for L-type calcium channel as antagonists for cadmium toxicity
por: Saddala, Madhu Sudhana, et al.
Publicado: (2017)

Sunflower-Assisted Bio-Derived ZnO-NPs as an Efficient Nanocatalyst for the Synthesis of Novel Quinazolines with Highly Antioxidant Activities
por: S., Mahesh, et al.
Publicado: (2022)

Relevance of Phosphorylation and Truncation of Tau to the Etiopathogenesis of Alzheimer’s Disease
por: Zhou, Yan, et al.
Publicado: (2018)

Plasma phosphorylated tau181 and neurodegeneration in Alzheimer’s disease
por: Hansson, Oskar, et al.
Publicado: (2020)

Plasma phosphorylated tau 217 in preclinical Alzheimer’s disease
por: Jonaitis, Erin M, et al.
Publicado: (2023)

Molecular docking analysis of acetylcholinesterase inhibitors for Alzheimer's disease management
por: Hakeem, Israa J
Publicado: (2023)

CGMD: An integrated database of cancer genes and markers
por: Pradeepkiran, Jangampalli Adi, et al.
Publicado: (2015)

Critical residues involved in tau binding to fyn: implications for tau phosphorylation in Alzheimer’s disease
por: Lau, Dawn H. W., et al.
Publicado: (2016)

PKR kinase directly regulates tau expression and Alzheimer's disease‐related tau phosphorylation
por: Reimer, Lasse, et al.
Publicado: (2020)

Absence of a Role for Phosphorylation in the Tau Pathology of Alzheimer’s Disease
por: Lai, Robert Y. K., et al.
Publicado: (2016)

Phosphorylation of different tau sites during progression of Alzheimer’s disease
por: Neddens, Joerg, et al.
Publicado: (2018)

Estimation of Tau and Phosphorylated Tau(181) in Serum of Alzheimer’s Disease and Mild Cognitive Impairment Patients
por: Shekhar, Shashank, et al.
Publicado: (2016)

Haloperidol inactivates AMPK and reduces tau phosphorylation in a tau mouse model of Alzheimer's disease
por: Koppel, Jeremy, et al.
Publicado: (2016)

Defective Autophagy and Mitophagy in Aging and Alzheimer’s Disease
por: Tran, Michael, et al.
Publicado: (2021)

Molecular Docking and Structure-Based Drug Design Strategies
por: Ferreira, Leonardo G., et al.
Publicado: (2015)

Development of Dual Inhibitors against Alzheimer's Disease Using Fragment-Based QSAR and Molecular Docking
por: Goyal, Manisha, et al.
Publicado: (2014)

Amyloid-beta and phosphorylated tau in post-mortem Alzheimer’s disease retinas
por: den Haan, Jurre, et al.
Publicado: (2018)

Is phosphorylated tau a good biomarker of synapse pathology in Alzheimer’s disease?
por: Saura, Carlos A, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5e0cbs6s5ci4egj8hcphae49dj